Cleared Abbreviated

K173075 - ZyMot ICSI Sperm Separation Device

K173075 is the FDA 510(k) clearance for ZyMot ICSI Sperm Separation Device by Dxnow, Inc.. It is a Class 2 Obstetrics & Gynecology device (product code MQK) cleared through the Abbreviated 510(k) pathway after a 160-day FDA review.

K173075 · Dxnow, Inc. · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2018
Decision
160d
Days
Class 2
Risk

K173075 is an FDA 510(k) clearance for the ZyMot ICSI Sperm Separation Device, ZyMot Multi Sperm Separation Device (850µ.... Classified as Labware, Assisted Reproduction (product code MQK), Class II - Special Controls.

Submitted by Dxnow, Inc. (Gaithersburg, US). The FDA issued a Cleared decision on March 8, 2018 after a review of 160 days - an extended review cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6160 - the FDA obstetrics and gynecology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Dxnow, Inc. devices

Submission Details

510(k) Number K173075 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 29, 2017
Decision Date March 08, 2018
Days to Decision 160 days
Submission Type Abbreviated
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
At panel average
Panel avg: 160d · This submission: 160d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code MQK Labware, Assisted Reproduction
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6160
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - MQK Labware, Assisted Reproduction

All 18
Devices cleared under the same product code (MQK) and FDA review panel - the closest regulatory comparables to K173075.
Rapid-i™ Kit
K181461 · Vitrolife Sweden AB · Jan 2019
Cryotop®US-flash and Cryotop®US-scoop
K181469 · Kitazato Corporation · Nov 2018
VitriGuard
K180740 · Origio A/S · May 2018
iVitri Straw
K172751 · Reprobitech Corp. · Feb 2018
RAPID-I KIT
K140207 · Vitrolife Sweden AB · Dec 2014
RAPID-I
K090832 · Vitrolife Sweden AB · Dec 2009